ResearcherLanzhou University Second HospitalActive in the last 2 years
Ru He
Matched on ORCID iD 0000-0002-9712-3386; OpenAlex author ID A5010356444. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2022: 3 papers · 2023: 2 papers · 2024: 1 paper
Papers 6
- Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030. Co-author DOI 10.1186/s12889-024-17875-6↗
- Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy. First author DOI 10.3389/fonc.2023.1185093↗
- Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis. Co-author DOI 10.3390/jpm13030409↗
- The relationships between antihypertensive medications and the overall survival of patients with pancreatic cancer: a systematic review and meta-analysis. First author DOI 10.1080/17474124.2022.2088506↗
- Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression. Co-author DOI 10.3389/fimmu.2022.1038650↗
- Challenges and Opportunities Associated With Platelets in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.850485↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wence Zhou · 5 shared papers, 2022–2024 · strength 1.05
- Paper Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to … DOI 10.1186/s12889-024-17875-6↗
- Paper The relationships between antihypertensive medications and the overall survival of patients with pancreatic cancer: a s… DOI 10.1080/17474124.2022.2088506↗
- Paper Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis. DOI 10.3390/jpm13030409↗
- Shi Dong · 3 shared papers, 2022–2023 · strength 0.55
- Paper Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis. DOI 10.3390/jpm13030409↗
- Paper Challenges and Opportunities Associated With Platelets in Pancreatic Cancer. DOI 10.3389/fonc.2022.850485↗
- Paper Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression. DOI 10.3389/fimmu.2022.1038650↗
- Wenkai Jiang · 2 shared papers, 2023–2024 · strength 0.48
- Paper Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to … DOI 10.1186/s12889-024-17875-6↗
- Paper Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis. DOI 10.3390/jpm13030409↗
- Zhengfeng Wang · 2 shared papers, 2022–2023 · strength 0.42
- Zhou Chen · 2 shared papers, 2022–2023 · strength 0.39
- Xin Li · 2 shared papers, 2022–2023 · strength 0.36
- Huaqing Shi · 2 shared papers, 2022–2023 · strength 0.36
- Xiao Li · 1 shared paper, 2024 · strength 0.28
- Wence Zhou · 1 shared paper, 2023 · strength 0.26
- Wenkai Jiang · 1 shared paper, 2022 · strength 0.22
- Fangfang Han · 1 shared paper, 2022 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.